SCHM:NYE-Schwab U.S. Mid-Cap ETF (USD)

ETF | Mid-Cap Blend |

Last Closing

USD 82.4

Change

-0.63 (-0.76)%

Market Cap

N/A

Volume

0.25M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Mid-Cap Blend

Symbol Name Price(Change) Market Cap
IJH iShares Core S&P Mid-Cap ETF

-0.43 (-0.69%)

USD 90.05B
IWR iShares Russell Mid-Cap ETF

-0.65 (-0.74%)

USD 36.50B
MDY SPDR® S&P MIDCAP 400 ETF Trus..

-3.89 (-0.68%)

USD 22.75B
VXF Vanguard Extended Market Index..

-1.46 (-0.80%)

USD 19.97B
SPMD SPDR Russell Small Cap Complet..

-0.38 (-0.70%)

USD 11.24B
XMHQ Invesco S&P MidCap Quality ETF

-0.97 (-0.95%)

USD 5.69B
JHMM John Hancock Multifactor Mid C..

-0.45 (-0.75%)

USD 4.00B
IVOO Vanguard S&P Mid-Cap 400 Index..

-0.70 (-0.66%)

USD 2.26B
EQAL Invesco Russell 1000 Equal Wei..

-0.41 (-0.84%)

USD 0.62B
FSMD Fidelity Small-Mid Factor

-0.35 (-0.85%)

USD 0.49B

ETFs Containing SCHM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.40% 39% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.40% 39% F 57% F
Trailing 12 Months  
Capital Gain 22.69% 47% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.69% 47% F 63% D
Trailing 5 Years  
Capital Gain 49.85% 37% F 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.85% 37% F 71% C-
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike